Characterization and molecular investigation of pathogenesis in a novel model of human familial ALS.
Characterization and molecular investigation of pathogenesis in a novel model of human familial ALS.
批准号:
G1000287/1
负责人:
Pietro Fratta
金额:
$33.02万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Amyotrophic lateral sclerosis, (ALS, also called Motor neurone disease) causes progressive paralysis due to the degeneration of motor nerve cells in the brain and spinal cord. People lose the ability to move their limbs, eat or speak and die from breathlessness, usually within 3 years of symptom onset. There is no effective treatment for the disease. ALS can occur in one individual or within families when a defective gene is passed down through the generations. No clinical characteristic differentiates the familial forms from the others. SOD1 is the most frequently involved gene and the study of SOD1 defects is an opportunity for understanding ALS disease mechanisms and to identify therapeutic targets. The purpose of this research project is to study a new mouse model which carries the exact same genetic defect as a group of ALS patients. We will characterize the disease progression in the mice and so we will use the mice to analyze the disease mechanisms in the motor nerve cells in the very early stages of disease. The discovery of underlying disease mechanisms is fundamental to the identifying drug targets for clinical trials, and the mice may also be used as a disease model to test new therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Loss of UNC13A: how it exacerbates amyotrophic lateral sclerosis, and how to correct it
-
批准号:MR/W005190/1
-
项目类别:Research Grant
-
资助金额:$107.91万
-
财政年份:2022
-
负责人:Pietro Fratta
-
依托单位:
The impact of TDP-43 on translation and the response to axonal damage in amyotrophic lateral sclerosis
-
批准号:MR/S006508/1
-
项目类别:Fellowship
-
资助金额:$245.45万
-
财政年份:2019
-
负责人:Pietro Fratta
-
依托单位:
RNA dysfunction in motor neuron disease: identification of novel changes in transcript processing and localisation through long-read RNA-seq
-
批准号:MC_PC_MR/S022708/1
-
项目类别:Research Grant
-
资助金额:$1.93万
-
财政年份:2018
-
负责人:Pietro Fratta
-
依托单位:
Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis
-
批准号:MR/M008606/1
-
项目类别:Fellowship
-
资助金额:$147.32万
-
财政年份:2015
-
负责人:Pietro Fratta
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: